医药研发年度回顾2026

10 (9)Johnson & Johnson198 (200)Source: Pharmaprojects, January 202613%1% DISTRIBUTION OF R&D COMPANIES BY HQ COUNTRY/REGIONThe race between the US and China continued in 2026. The number ofcompanies involved in pharma R&D headquartered in the US grew slightly to41% in 2026 from 39% in 2025. The proportion of China-based firms involvedin R&D edged up as well, rising to 19% in 2026 from 17% in 2025. While France,Germany, and the UK held firm, the rest of Europe looked to be in retreat.Distribution of R&D companies by HQ country/region, 2025 and 2026202539%3%17%3%2%3%14%5%20252026 Copyright ©️ 2026 Citeline, a Norstella company.